Frequency Therapeutics (NASDAQ: FREQ)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.670 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Frequency Therapeutics (NASDAQ: FREQ) through any online brokerage.
Other companies in Frequency Therapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Connect Biopharma Hldgs (NASDAQ:CNTB), Evaxion Biotech (NASDAQ:EVAX), Aligos Therapeutics (NASDAQ:ALGS) and Infinity Pharmaceuticals (NASDAQ:INFI).
The latest price target for Frequency Therapeutics (NASDAQ: FREQ) was reported by Goldman Sachs on Tuesday, May 24, 2022. The analyst firm set a price target for 2.00 expecting FREQ to rise to within 12 months (a possible 34.23% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Frequency Therapeutics (NASDAQ: FREQ) is $1.49 last updated Today at July 6, 2022, 5:24 PM UTC.
There are no upcoming dividends for Frequency Therapeutics.
Frequency Therapeutics’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Frequency Therapeutics.
Frequency Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.